|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ʸ�˹ϸ�� |
|
��ԭ��� |
|
����ѧ���� |
| ��������������� | |
|
���������� |
|
�˾���У |
| PubMed | |
|
Article by |
|
Article by |
��Ƥ�ʸ�˹ϸ���Ŀ�ԭ��Ｐ������ѧ���õ��о���չ
����������, �˾���У
�ڶ���ҽ��ѧ����ҽԺƤ����
�ʸ�˹ϸ���DZ�Ƥ�ڵ���Ҫ��ԭ�ݳ�ϸ��,����ȡ�ʹ���ԭ,�����������������ܰͽ�,�T����ϸ�������Ķ�������������LC�Ĺ�����صĿ�ԭ��Ｐ������ѧ���õ��о����������������
[2] Blauvelt A, Katz SI, Udey MC. Human Langerhans cells express E-cadherin. J Invest Dermatol, 1995,104(2):293-296.
[3] Aiba S, Manome H, Yoshino Y, et al. In vitro treatment of human transforming growth facto 1-beta 1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional change similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology, 2000,101(1):68-75.
[4] Yasaka N, Furue M, Tamake K, et al. Expression of cutaneous lymphocyte-associated antigen defined by monoclonal antibody HECA-452 on human Langerhans cells. J Dermatol Sci, 1996,11(1):19-27.
[5] Wang B, Kondo S, Shivji GM, et al. Tumour necrosis factor receptor ��(p75) signalling is required for the migration of Langerihans' cells. Immunology, 1996,88(2):284-288.
[6] Ariizumi K, Kitajima T, Bergstresser OR, et al. Interleukin-1 beta converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. Eur J Immunol, 1995,25(8):2137-2141.
[7] Charbonnier AS, Kohrgruber N, Kriehuber E, et al. Macrophage inflammatory protein 3 alpha is invoved in the constitive trafficking of epidermal Langerhans cells. J Exp Med, 1999,190(12):1755-1768.
[8] Kobayashi Y. Langerhans cells produce type V collagenase(MMP-9) following epicutaneous stimulation with haptens. Immunology, 1997,90(4):496-501.
[9] Price AA, Cumberbatch M, Kimber I, et al. Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med,1997, 186(10):1725-1735.
[10] Kawamura T, Furue M. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells:differential regulation by T helper type and T helper type 2 cytokines. Eur J Immunol, 1995,25(7):1913-1917.
[11] Ozawa H, Aiba S, Nakagawa, et al. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80(B7-1) expression. Eur J Immunol, 1996,26(3):648-652.
[12] Salgado CG, Nakamura K, Sugaya M, et al. Differential effects of cytokines and immunosuppressive drugs on CD40, B7-1, and B7-2 expression on purified epidemal Langerhans cells. J Invest Dermatol, 1999,113(6):1021-1027.
[13] Reiser H, Schneeberger EE. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur J Immunol, 1996, 26(4):880-885.
[14] Teunissen MB, Koomen CW, Bos JD. Intercellular adhesion molecule-3(CD50)on human epidermal Langerhans cells participates in T-cells activation. J Invest Dermatol, 1995,104(6):995-998.
[15] Esposito-Faress ME, Sautes C, de la Salle H, et al. Membrane and soluble Fc gamma R��/�� modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J Immunol, 1995,155(4):1725-1736.
[16] de la Salle H, Haegal-Kronenberger H, Bausinger H, et al. Functions of Fc receptors on human dendritic Langerhans cells. Int Rev Immunol, 1997,16(1-2):187-203.
[17] Shibake A, Ohkawara A, Shimada S, et al. Expression,but lack of calcium mobilization by high-affinity IgE Fc epsilon receptor �� on human epidermal and dermal Langerhans cells. Exp Dermatol, 1996, 5(5):272-278.
[18] Cumberbatch M, Dearmam RJ, Kimmber I, et al. Constitutive and inducible expression of interleukin-6 by Langerhans cells and 1ymph node dendritic cells. Immunology, 1996,87(4):513-518.